The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0.61%Dividend Yield

Mar 26

$0.06

Dec 25

$0.11

Sep 25

$0.1

Jun 25

$0.1

Mar 25

$0.15

10Y Growth

4.23%

5Y Growth

-3.23%

3Y Growth

-11.28%

1Y Growth

-19.87%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XPH. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Invesco Pharmaceuticals

PJP

Mkt Cap0

Powershares Dynamic Pharmaceuticals ETF, directly competes by investing in pharmaceutical companies.

iShares U.S. Pharmaceuticals

IHE

Mkt Cap0

iShares U.S. Pharmaceuticals ETF, targets U.S. pharmaceutical companies, similar to XPH's focus.

Fidelity MSCI Health Care Index

FHLC

Mkt Cap0

Fidelity MSCI Health Care Index ETF, includes pharmaceuticals within the broader health care sector, competing for the same investment dollars.

Vanguard Health Care

VHT

Mkt Cap0

Vanguard Health Care ETF, covers health care including pharmaceuticals, offering an alternative within the same sector.

State Street Health Care Select Sector SPDR

XLV

Mkt Cap0

Health Care Select Sector SPDR Fund, competes by focusing on health care, including pharmaceutical companies.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF, competes by investing in biotech and pharmaceuticals, offering exposure to drug development.

iShares Biotechnology

IBB

Mkt Cap0

iShares Biotechnology ETF, includes pharmaceuticals in its broader biotech category, competing for similar investment focus.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF, competes by offering exposure to biotech, which includes companies involved in pharmaceuticals.

Johnson & Johnson

JNJ

Mkt Cap546.9B

Johnson & Johnson, a major player in the pharmaceutical industry, represents direct competition through individual company investment.

Pfizer

PFE

Mkt Cap149.77B

Pfizer Inc, another leading pharmaceutical company, competes as a direct investment alternative in the pharmaceutical space.

Holdings

Regions

Sectors

About

The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

CEO

Country

United States

ISIN

US78464A7220

Listings

0 Comments

Share your thoughts

FAQ

What is State Street SPDR S&P Pharmaceuticals stock price today?▼

The current price of XPH is $60.7 USD — it has increased by +1.56% in the past 24 hours. Watch State Street SPDR S&P Pharmaceuticals stock price performance more closely on the chart.

What is State Street SPDR S&P Pharmaceuticals stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange State Street SPDR S&P Pharmaceuticals stocks are traded under the ticker XPH.

Is State Street SPDR S&P Pharmaceuticals stock price growing?▼

XPH stock has risen by +5.36% compared to the previous week, the month change is a +11.21% rise, over the last year State Street SPDR S&P Pharmaceuticals has showed a +52.36% increase.

Does State Street SPDR S&P Pharmaceuticals pay dividends?▼

Yes, XPH dividends are paid quarterly. The last dividend per share was 0.06 USD. As of today, Dividend Yield (FWD)% is 0.61%.

In which sector is State Street SPDR S&P Pharmaceuticals located?▼

State Street SPDR S&P Pharmaceuticals operates in the Other sector.

When did State Street SPDR S&P Pharmaceuticals complete a stock split?▼

The last stock split for State Street SPDR S&P Pharmaceuticals was on September 11, 2015 with a ratio of 2:1.